US 7572914
Kinase inhibitors
granted A61PA61P1/04A61P15/18
Quick answer
US patent 7572914 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 86
- CPC classes
- A61P, A61P1/04, A61P15/18, A61P17/06, A61P17/14